I et centralt fase- III nyre- studie var den gennemsnitlige sensitivitet 91% (patient- baseret analyse) og 85% (læsions- baseret analyse) for klassificering af maligne og benigne nyrelæsioner.
In a pivotal phase III kidney study average sensitivity was 91% (patient-based analysis) and 85% (lesion-based analysis) for classification of malignant and benign renal lesions.